Urszula Masiukiewicz, MD
Senior Director, Global Clinical Research and Development
Research & Publications
Biography
News
Coauthors
Selected Publications
- Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV)Cannon CP, McGuire DK, Pratley R, Dagogo-Jack S, Mancuso J, Huyck S, Charbonnel B, Shih WJ, Gallo S, Masiukiewicz U, Golm G, Cosentino F, Lauring B, Terra SG, Investigators V. Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). American Heart Journal 2018, 206: 11-23. PMID: 30290289, DOI: 10.1016/j.ahj.2018.08.016.
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk PatientsRidker PM, Revkin J, Amarenco P, Brunell R, Curto M, Civeira F, Flather M, Glynn RJ, Gregoire J, Jukema JW, Karpov Y, Kastelein JJP, Koenig W, Lorenzatti A, Manga P, Masiukiewicz U, Miller M, Mosterd A, Murin J, Nicolau JC, Nissen S, Ponikowski P, Santos RD, Schwartz PF, Soran H, White H, Wright RS, Vrablik M, Yunis C, Shear CL, Tardif JC. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients. New England Journal Of Medicine 2017, 376: 1527-1539. PMID: 28304242, DOI: 10.1056/nejmoa1701488.
- Oral Apixaban for the Treatment of Acute Venous ThromboembolismAgnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI. Oral Apixaban for the Treatment of Acute Venous Thromboembolism. New England Journal Of Medicine 2013, 369: 799-808. PMID: 23808982, DOI: 10.1056/nejmoa1302507.
- Calcium homeostasis and disorders of calcium metabolism during pregnancy and lactationMasiukiewicz U, Insogna K. Calcium homeostasis and disorders of calcium metabolism during pregnancy and lactation. In Medical Complications During Pregnancy, 6th edition. Burrow G, Duffy T, editors.
- Maternal calcium and skeletal homeostasis during pregnancy and lactationMasiukiewicz U, Insogna K. Maternal calcium and skeletal homeostasis during pregnancy and lactation. In The DeGrooth Textbook of Endocrinology, DeGrooth L, Burrow G, editors. Endotext.org., 2003.
- Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women.Insogna K, Mitnick M, Pascarella J, Nakchbandi I, Grey A, Masiukiewicz U. Role of the interleukin-6/interleukin-6 soluble receptor cytokine system in mediating increased skeletal sensitivity to parathyroid hormone in perimenopausal women. Journal Of Bone And Mineral Research 2002, 17 Suppl 2: n108-16. PMID: 12412787.
- Evidence that the IL-6/IL-6 Soluble Receptor Cytokine System Plays a Role in the Increased Skeletal Sensitivity to PTH in Estrogen-Deficient WomenMasiukiewicz US, Mitnick M, Gulanski BI, Insogna KL. Evidence that the IL-6/IL-6 Soluble Receptor Cytokine System Plays a Role in the Increased Skeletal Sensitivity to PTH in Estrogen-Deficient Women. The Journal Of Clinical Endocrinology & Metabolism 2002, 87: 2892-2898. PMID: 12050269, DOI: 10.1210/jcem.87.6.8577.
- IL-6 Negatively Regulates IL-11 Production in Vitro and in VivoNakchbandi I, Mitnick M, Masiukiewicz U, Sun B, Insogna K. IL-6 Negatively Regulates IL-11 Production in Vitro and in Vivo. Endocrinology 2001, 142: 3850-3856. DOI: 10.1210/en.142.9.3850.
- Cytokines in Primary Hyperparathyroidism10. Nakchbandi I, Masiukiewicz U, Mitnick M, Grey A, Insogna K. Cytokines in Primary Hyperparathyroidism. In The Parathyroids 2nd edition. J. Belizikan, M Levine, R Marcus eds. Academic Press. 411-421, 2001
- Estrogen Modulates Parathyroid Hormone-Induced Interleukin-6 Production in Vivo and in Vitro*Masiukiewicz U, Mitnick M, Grey A, Insogna K. Estrogen Modulates Parathyroid Hormone-Induced Interleukin-6 Production in Vivo and in Vitro*. Endocrinology 2000, 141: 2526-2531. DOI: 10.1210/en.141.7.2526.
- Papillary Thyroid Carcinoma Metastatic to the Pituitary GlandMasiukiewicz US, Nakchbandi IA, Stewart AF, Inzucchi SE. Papillary Thyroid Carcinoma Metastatic to the Pituitary Gland. Thyroid 1999, 9: 1023-1027. PMID: 10560958, DOI: 10.1089/thy.1999.9.1023.
- A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo1Grey A, Mitnick M, Masiukiewicz U, Sun B, Rudikoff S, Jilka R, Manolagas S, Insogna K. A Role for Interleukin-6 in Parathyroid Hormone-Induced Bone Resorption in Vivo1. Endocrinology 1999, 140: 4683-4690. DOI: 10.1210/en.140.10.4683.
- Hyperthyroidism in Pregnancy: Diagnosis and TreatmentMasiukiewicz US, Burrow GN. Hyperthyroidism in Pregnancy: Diagnosis and Treatment. Thyroid 1999, 9: 647-652. PMID: 10447008, DOI: 10.1089/thy.1999.9.647.
- The role of parathyroid hormone in the pathogenesis, prevention and treatment of postmenopausal osteoporosisMasiukiewicz US, Insogna KL. The role of parathyroid hormone in the pathogenesis, prevention and treatment of postmenopausal osteoporosis. Aging Clinical And Experimental Research 1998, 10: 232-239. PMID: 9801733, DOI: 10.1007/bf03339657.
- Prolonged use of etomidate infusion to control severe hypercortisolemia in a patient with Cushing's diseaseMasiukiewicz U, Inzucchi SE. Prolonged use of etomidate infusion to control severe hypercortisolemia in a patient with Cushing's disease. Proceedings of the 80th Meeting of the Endocrine Society. pg 507, 1998.
- [Clinical pharmacology of flecainide].Rewerski W, Walczak F, Nyznyk M, Dorociak A, Skorupska U. [Clinical pharmacology of flecainide]. Polski Tygodnik Lekarski (Warsaw, Poland : 1960) 1988, 43: 1161-5. PMID: 3150783.
- Propafenone in reentry tachycardiaWalczak F, Gottner B, Skorupska (Masiukiewicz) U, Nyznyk M, Wysocki M, Rembelska H, Jedynak Z, Rewerski W. Hoffman M. Propafenone in reentry tachycardia. Pharmacol Clin. 4:26, 1988
- International Symposium on Clinical Pharmacology, Propafenone in Reentry TachycardiaWalczak F, Gotter B, Skorupska (Masiukiewicz) U, Nyznyk M, Wysocki M, Rembelska H, Jedynak Z, Reweski W, Hoffman M. International Symposium on Clinical Pharmacology, Propafenone in Reentry Tachycardia. Wroclaw, Poland, 1988
- Einfluss des Propafenones auf Reentry TachycardienWalczak F, Gotter B, Skorupska (Masiukiewicz) U, Nyznyk M, Wysocki M, Rembelska H, Poplawska W, Jedynak Z, Hoffman M. Einfluss des Propafenones auf Reentry Tachycardien. XIII Kongres der Geselshaft fur Kardiologie und Angiologie der, Germany, Gera, 1987.